Current NDC auxiliary source row compounder:2995

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 71300-6622
Product Ndc: 71300-6622
Product Ndc Digits: 713006622
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: LIDOCAINE HCL AND TETRACAINE HCL
Proprietary Name Suffix: [empty]
Nonproprietary Name: Lidocaine HCl and Tetracaine HCl
Dosage Form Name: INJECTION
Route Name: EPIDURAL; INTRA-ARTICULAR; SOFT TISSUE; SUBCUTANEOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Nubratori Inc.
Establishment Name: Nubratori Inc.
Establishment Fei: [empty]
Substance Name: LIDOCAINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE
Active Ingredients Info: 4 mg/1 mL; 2 mg/1 mL
History Active Ingredients Raw: LIDOCAINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE
History Active Ingredients Info Raw: 4 mg/1 mL; 2 mg/1 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 71300-6622-5
Package Ndc: 71300-6622-5
Package Ndc Digits: 7130066225
Package Ndc11: 71300662205
Package Description: 50 mL in 1 VIAL (71300-6622-5)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:2995
Source Row Number: 2995
Source Row Hash: 7384977b3492578c3e978bf579893acc26e8cc890534c85cbf7e34eb495df8d4
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01

Exact raw FDA source fields#

{
    "ROUTENAME": "EPIDURAL; INTRA-ARTICULAR; SOFT TISSUE; SUBCUTANEOUS",
    "PRODUCTNDC": "71300-6622",
    "DEASCHEDULE": "",
    "LABELERNAME": "Nubratori Inc.",
    "SUBSTANCENAME": "LIDOCAINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "71300-6622-5",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "LIDOCAINE HCL AND TETRACAINE HCL",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Lidocaine HCl and Tetracaine HCl",
    "PACKAGEDESCRIPTION": "50 mL in 1 VIAL (71300-6622-5) ",
    "ACTIVEINGREDIENTSINFO": "4 mg/1 mL; 2 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:2995
Source Row Number: 2995
Status Scope: package
Lookup Ndc: 71300-6622-5
Lookup Ndc Digits: 7130066225
Product Ndc: 71300-6622
Product Ndc Digits: 713006622
Package Ndc: 71300-6622-5
Package Ndc Digits: 7130066225
Package Ndc11: 71300662205
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 7384977b3492578c3e978bf579893acc26e8cc890534c85cbf7e34eb495df8d4
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01